Pilot funding mechanisms are vital to developing and testing innovative new ideas. NUCATS supports a wide array of pilot and seed-grant funding opportunities to advance clinical and translational science. They span the spectrum of clinical and translational science, from early translational “Proof-of-Concept” Awards to the Alliance for Research in Chicagoland Communities (ARCC) seed grants for capacity-building and pilot funding in academic-community research partnerships. These pilot programs are supported variably by institutional, targeted philanthropic, or Clinical and Translational Science Awards (CTSA) funds and create a portfolio of opportunities for investigators across every phase of clinical and translational science focused on any disease.
PTC by the numbers:
- Since 2008, the Dixon Translatinal Awards has awarded $5,769,440 to 67 grant recipients conducting innovative studies in all areas of medicine, from heart disease and cancer to diabetes and wound healing.
- In 2014, NUCATS funded four competitive awards (out of 13 applications) for a total of $200,000 to advance the commercialization potential of promising compounds/targets in our therapeutics development pipeline.
- In 2014, the NUCATS Pilot Program awarded four pilot awards (out of 7 applications) for the July 2014 competition.
- In 2015, the NUCATS Pilot Program awarded four pilot awards (out of 20 applications) for the Nov 2014 competition.
An overview of PTC.
The leadership and governance structure of PTC.
Discover the pilot and seed-grant funding opportunities NUCATS supports.
Read about the awardees and their work.